169 related articles for article (PubMed ID: 16407196)
1. Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA.
Ying M; Xu R; Wu X; Zhu H; Zhuang Y; Han M; Xu T
J Biol Chem; 2006 May; 281(18):12580-6. PubMed ID: 16407196
[TBL] [Abstract][Full Text] [Related]
2. Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy.
Suzuki Y; Yazawa I
Int J Clin Exp Pathol; 2011 Apr; 4(4):378-84. PubMed ID: 21577324
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity.
Nucifora FC; Ellerby LM; Wellington CL; Wood JD; Herring WJ; Sawa A; Hayden MR; Dawson VL; Dawson TM; Ross CA
J Biol Chem; 2003 Apr; 278(15):13047-55. PubMed ID: 12464607
[TBL] [Abstract][Full Text] [Related]
4. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA.
Schilling G; Wood JD; Duan K; Slunt HH; Gonzales V; Yamada M; Cooper JK; Margolis RL; Jenkins NA; Copeland NG; Takahashi H; Tsuji S; Price DL; Borchelt DR; Ross CA
Neuron; 1999 Sep; 24(1):275-86. PubMed ID: 10677044
[TBL] [Abstract][Full Text] [Related]
5. Atrophin-1 Function and Dysfunction in Dentatorubral-Pallidoluysian Atrophy.
Nowak B; Kozlowska E; Pawlik W; Fiszer A
Mov Disord; 2023 Apr; 38(4):526-536. PubMed ID: 36809552
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3.
Chou AH; Chen SY; Yeh TH; Weng YH; Wang HL
Neurobiol Dis; 2011 Feb; 41(2):481-8. PubMed ID: 21047555
[TBL] [Abstract][Full Text] [Related]
7. C-terminal deletion of the atrophin-1 protein results in growth retardation but not neurodegeneration in mice.
Yu J; Ying M; Zhuang Y; Xu T; Han M; Wu X; Xu R
Dev Dyn; 2009 Oct; 238(10):2471-8. PubMed ID: 19681162
[TBL] [Abstract][Full Text] [Related]
8. Dentatorubral-pallidoluysian atrophy.
Tsuji S
Handb Clin Neurol; 2012; 103():587-94. PubMed ID: 21827919
[TBL] [Abstract][Full Text] [Related]
9. Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy.
Nisoli I; Chauvin JP; Napoletano F; Calamita P; Zanin V; Fanto M; Charroux B
Cell Death Differ; 2010 Oct; 17(10):1577-87. PubMed ID: 20339376
[TBL] [Abstract][Full Text] [Related]
10. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
[TBL] [Abstract][Full Text] [Related]
11. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.
Luthi-Carter R; Strand AD; Hanson SA; Kooperberg C; Schilling G; La Spada AR; Merry DE; Young AB; Ross CA; Borchelt DR; Olson JM
Hum Mol Genet; 2002 Aug; 11(17):1927-37. PubMed ID: 12165555
[TBL] [Abstract][Full Text] [Related]
12. Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice.
Sato T; Miura M; Yamada M; Yoshida T; Wood JD; Yazawa I; Masuda M; Suzuki T; Shin RM; Yau HJ; Liu FC; Shimohata T; Onodera O; Ross CA; Katsuki M; Takahashi H; Kano M; Aosaki T; Tsuji S
Hum Mol Genet; 2009 Feb; 18(4):723-36. PubMed ID: 19039037
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of neurodegeneration in dentatorubral-pallidoluysian atrophy (DRPLA)].
Tsuji S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1064-6. PubMed ID: 12235796
[TBL] [Abstract][Full Text] [Related]
14. Increased aggregation of polyleucine compared with that of polyglutamine in dentatorubral-pallidoluysian atrophy protein.
Suzuki Y; Jin C; Yazawa I
Neurosci Lett; 2013 Sep; 552():156-61. PubMed ID: 23933208
[TBL] [Abstract][Full Text] [Related]
15. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.
Yamada M; Shimohata M; Sato T; Tsuji S; Takahashi H
Neuropathology; 2006 Aug; 26(4):346-51. PubMed ID: 16961072
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.
Ferrante RJ; Kubilus JK; Lee J; Ryu H; Beesen A; Zucker B; Smith K; Kowall NW; Ratan RR; Luthi-Carter R; Hersch SM
J Neurosci; 2003 Oct; 23(28):9418-27. PubMed ID: 14561870
[TBL] [Abstract][Full Text] [Related]
17. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death.
Terashima T; Kawai H; Fujitani M; Maeda K; Yasuda H
Neuroreport; 2002 Dec; 13(17):2359-64. PubMed ID: 12488827
[TBL] [Abstract][Full Text] [Related]
18. [Formation of neuronal inclusions and neurodegeneration: with special reference to dentatorubral-pallidoluysian atrophy].
Takahashi H
Rinsho Shinkeigaku; 1999 Dec; 39(12):1279-81. PubMed ID: 10791097
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy.
Suzuki Y; Nakayama K; Hashimoto N; Yazawa I
FEBS J; 2010 Dec; 277(23):4873-87. PubMed ID: 20977674
[TBL] [Abstract][Full Text] [Related]
20. Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease.
Kanazawa I
Neurogenetics; 1998 Dec; 2(1):1-17. PubMed ID: 9933295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
